deltatrials
Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm NCT07145645

Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children (TOP-MAP)

Topical Diclofenac vs. Oral Ibuprofen for Musculoskeletal Pain in Children: A Multi-centre, Randomized Pilot Feasibility Trial

Sponsor: Hamilton Health Sciences Corporation

Updated 1 time since 2025 Last updated: Aug 20, 2025 Started: Sep 2, 2025 Primary completion: Sep 30, 2027 Completion: Mar 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07145645, this PHASE3 trial focuses on Musculoskeletal Injury and Pediatrics and remains actively recruiting participants. Sponsored by Hamilton Health Sciences Corporation, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2025 – present · 11 months · monthly snapshotNot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting — PHASE3 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hamilton Health Sciences Corporation
  • University of Calgary
Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.